Evidence map›Paper›PMID 33096942›Full record

ArticleBiomolecules2020

Shogo Abe, Misako Ueno, Mami Nishitani, Tetsuya Akamatsu, Takumi Sato, Marie Shimoda, Hiroki Kanaoka, Yoshitaka Nii, Hiroko Yamasaki, Keizo Yuasa

Abstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Bioinformatics analysis identification ofExperimental and therapeutic medicine · 2022
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shogo AbeDepartment of Biological Science and Technology, Tokushima University Graduate School, 2-1 Minamijosanjima-cho, Tokushima 770-8506, Japan.
Misako UenoDepartment of Bioscience and Bioindustry, Tokushima University Graduate School, 2-1 Minamijosanjima-cho, Tokushima 770-8513, Japan.
Mami NishitaniDepartment of Biological Science and Technology, Tokushima University Graduate School, 2-1 Minamijosanjima-cho, Tokushima 770-8506, Japan.
Tetsuya AkamatsuDepartment of Bioscience and Bioindustry, Tokushima University Graduate School, 2-1 Minamijosanjima-cho, Tokushima 770-8513, Japan.ORCID 0000-0002-2134-860X
Takumi SatoDepartment of Bioscience and Bioindustry, Tokushima University Graduate School, 2-1 Minamijosanjima-cho, Tokushima 770-8513, Japan.
Marie ShimodaResearch and Development Department, Matsuyama Co., Ltd., 11-2 Nishibari, Saika-cho, Tokushima 770-8021, Japan.
Hiroki KanaokaResearch and Development Department, Matsuyama Co., Ltd., 2-17-8 Higashi-sumida, Sumida-ku, Tokyo 131-0042, Japan.
Yoshitaka NiiFood and Biotechnology Division, Tokushima Prefectural Industrial Technology Center, 11-2 Nishibari, Saika-cho, Tokushima 770-8021, Japan.
Hiroko YamasakiResearch and Development Department, Matsuyama Co., Ltd., 2-17-8 Higashi-sumida, Sumida-ku, Tokyo 131-0042, Japan.
Keizo YuasaDepartment of Biological Science and Technology, Tokushima University Graduate School, 2-1 Minamijosanjima-cho, Tokushima 770-8506, Japan.ORCID 0000-0003-4831-0465

Funding

The Awa Bank Science and Culture Foundation of Tokushima .
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Squamous CellCell DifferentiationCell Line, TumorCell ProliferationCitrusErbB ReceptorsFruitGene Expression Regulation, NeoplasticHumansKeratinocytesSignal TransductionSkin NeoplasmsEGFR protein, humanErbB Receptorscell proliferation and differentiationcitrus peel extractEGF–EGFR–ERKkeratinocyte

Identifiers

PMID33096942
PMCPMC7589747

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.